The FDA reviews MDMA clinical trial data for PTSD treatment approval.

The FDA is reviewing clinical trial data to determine if MDMA, commonly known as Ecstasy, can be approved as a treatment for PTSD. Some trial participants have described the treatment as transformational, but the Institute for Clinical and Economic Review has raised concerns about the study's results' validity. Biden is also set to issue an executive order on border policy.

June 04, 2024
20 Articles